Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis
Authors:
- 1 April 2016
- journal article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 37, 8-12
Abstract
No abstract availableKeywords
Funding Information
- Inha University
This publication has 22 references indexed in Scilit:
- Lack of Pharmacokinetic Interaction of Levetiracetam on Carbamazepine, Valproic Acid, Topiramate, and Lamotrigine in Children with EpilepsyEpilepsia, 2007
- TopiramateDrugs, 2007
- Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsyClinical Therapeutics, 2005
- Pharmacokinetic and Metabolic Investigation of Topiramate Disposition in Healthy Subjects in the Absence and in the Presence of Enzyme Induction by CarbamazepineEpilepsia, 2005
- Topiramate Pharmacokinetics in Children and Adults with EpilepsyClinical Pharmacokinetics, 2005
- Topiramate Serum Concentration-to-Dose RatioTherapeutic Drug Monitoring, 2004
- Pharmacokinetic Interactions of TopiramateClinical Pharmacokinetics, 2004
- Topiramate as Add‐On Therapy: Pooled Analysis of Randomized Controlled Trials in AdultsEpilepsia, 2000
- A PHARMACOLOGICAL AND CLINICAL REVIEW ON TOPIRAMATE, A NEW ANTIEPILEPTIC DRUGPharmacological Research, 1997
- Comparison of the Steady‐State Pharmacokinetics of Topiramate and Valproate in Patients with Epilepsy During Monotherapy and Concomitant TherapyEpilepsia, 1997